AryoTrust® (Trastuzumab) Safety Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review
- Status
- COMPLETED
- Phase
- N/A
DP303c in Patients With HER2-positive Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
- Status
- RECRUITING
- Phase
- PHASE1
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study
- Status
- UNKNOWN
- Phase
- NA